ESMO 20th World Congress on Gastrointestinal Cancer has ended
Back To Schedule
Thursday, June 21 • 12:00 - 12:30
Presentation of selected abstracts

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Overall survival results from a Phase III trial of trifluridine/tipiracil vs. placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS)
Josep Tabernero, et al., LBA-002
KEYNOTE-061: phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
Kohei Shitara, et al., LBA-005

Thursday June 21, 2018 12:00 - 12:30 PDT
Auditorium A, Level 0